Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
Across the globe, three out of five people die from conditions linked to chronic inflammation, including heart disease, stroke, diabetes, and cancer
Ethoxybenzylimidazole (NEBI) Linkers These cleavable linkers use the hydrolysis of aminol ether for drug release
BPC-157s only human studies were early-phase trials for inflammatory bowel disease
And this question has to do with
It helps protect your cells from damage and supports your immune function